Garvan Institute – Sarcoma Research

Using whole-genome sequencing to research deeply into our DNA has led to the discovery that all disease is linked to genetic mutations so that instead of trying to treat disease symptoms, we can now target the mutations causing them. This is personalised medicine.  Read more about the outstanding work of the Garvan Institute, providing untold hope for sarcoma patients.

https://www.garvan.org.au/research/diseases/sarcoma/research

Therapeutic target for Ewing sarcoma

The sarcoma research group of the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr. Òscar Martínez-Tirado, has identified a potential new therapeutic target for Ewing sarcoma, the second most frequent bone cancer in children and adolescents, and a tumour known by its aggressiveness and tendency to metastasise.

https://www.news-medical.net/news/20180405/Researchers-discover-potential-new-therapeutic-target-for-Ewing-sarcoma.aspx

ASSG 2018 Sarcoma Research Grants

ASSG Research Grants 2018

ASSG have four grants on offer funded by generous donors, and are awarded for direct research costs. Selection criteria include track record and project feasibility, innovation and excellence. Please click on the links below for individual grant information.

The Johanna Sewell Sarcoma Research Grant
 $50,000 for one year

The Leon Stone Sarcoma Research Grant $20,000 for one year

The Xavier Krikori Sarcoma Research Grant $20,000 for one year

The Hannah’s Chance Sarcoma Research Grant $30,000 for one year

 

http://www.australiansarcomagroup.org/2018-sarcoma-research-grants.html